Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-054278
Filing Date
2017-09-28
Accepted
2017-09-28 17:16:45
Documents
2
Period of Report
2017-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3903
2 POA DOCUMENT poa.txt EX-24.4_745602 4255
  Complete submission text file 0001209191-17-054278.txt   9643
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
Giles Richard B (Reporting) CIK: 0001525268 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 171108348